WASHINGTON, April 15, 2020 /PRNewswire/ — Today, the Association of Black Cardiologists (ABC) issued frequently asked questions (FAQ Watch) for healthcare providers related to COVID-19. The novel coronavirus outbreak has caused significant disruption to global health, especially for vulnerable populations in the U.S. The ABC created FAQ Watch to provide a succinct update on the science and…
The ABC along with the American College of Cardiology (ACC), the American Heart Association and 11 other cardiovascular and health care society leaders joined together on March 30 to express concern “over the critical shortages of medical equipment, including ventilators, test kits and all types of personal protective equipment (PPE) such as masks, face shields…
CMS Outlines New Flexibilities Available to People with Medicare The Trump Administration today announced expanded Medicare telehealth coverage that will enable beneficiaries to receive a wider range of healthcare services from their doctors without having to travel to a healthcare facility. Beginning on March 6, 2020, Medicare—administered by the Centers for Medicare & Medicaid…
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed BRILINTA (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus BRILINTA in high-risk coronary patients. One subgroup analysis (TWILIGHT-DM) included patients with diabetes who had undergone a successful percutaneous coronary intervention (PCI),…
ABC Partner and Corporate Member Esperion announced this week that their NEXLETOL™ (bempedoic acid) tablet, an oral, once-daily, non-statin LDL-Cholesterol (LDL-C) lowering medicine is now available in U.S. pharmacies. ABC Access to Care Initiative Chair, Dr. Keith C. Ferdinand, applauds availability to this new drug. Comment: “The approval of new cardiovascular therapies will continue, even…
ANN ARBOR, Mich., March 30, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) announced today that NEXLETOL™ (bempedoic acid) tablet, an oral, once-daily, non-statin LDL-Cholesterol (LDL-C) lowering medicine is now available in U.S. pharmacies. Esperion is committed to respecting the valuable time of healthcare providers in the current environment while also remaining steadfast to the patients…